Parkinson's disorder, psychomotor and dopaminergic neurotoxicity in problems recreational ecstasy/MDMA users

被引：3
|
作者：
Parrott, AC [1 ]
Buchanan, T
Heffernan, TM
Scholey, A
Ling, J
Rodgers, J
机构：
[1] Univ E London, Dept Psychol, London E15 4LZ, England
[2] Univ Westminster, London W1R 8AL, England
[3] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England
[4] Univ Teesside, Middlesbrough, Cleveland, England
[5] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
PSYCHOPHARMACOLOGY | 2003年 / 167卷 / 04期
关键词：
D O I：
10.1007/s00213-003-1447-5
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：449 / 450
页数：2
相关论文
共 50 条
  • [1] Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users
    A. C. Parrott
    T. Buchanan
    T. M. Heffernan
    A. Scholey
    J. Ling
    J. Rodgers
    [J]. Psychopharmacology, 2003, 167 : 449 - 450
  • [2] The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003)
    Parrott, AC
    Rodgers, J
    Buchanan, T
    Scholey, AB
    Heffernan, T
    Ling, J
    [J]. PSYCHOPHARMACOLOGY, 2004, 171 (02) : 231 - 233
  • [3] The reality of psychomotor problems, and the possibility of Parkinson’s disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003)
    A. C. Parrott
    J. Rodgers
    T. Buchanan
    A. B. Scholey
    T. Heffernan
    J. Ling
    [J]. Psychopharmacology, 2004, 171 : 231 - 233
  • [4] Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson’s disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449–450
    H. R. Sumnall
    L. Jerome
    R. Doblin
    M. C. Mithoefer
    [J]. Psychopharmacology, 2004, 171 : 229 - 230
  • [5] Response to:: !Parrott AC, !Buchanan T, !Heffernan TM, !Scholey A, !Ling J, !Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.: Psychopharmacology 167(4):449-450
    Sumnall, HR
    Jerome, L
    Doblin, R
    Mithoefer, MC
    [J]. PSYCHOPHARMACOLOGY, 2004, 171 (02) : 229 - 230
  • [6] MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users
    Parrott, Andrew C.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (08): : 1466 - 1484
  • [7] Recreational MDMA (Ecstasy) use and serotonergic neurotoxicity
    不详
    [J]. NEUROSCIENTIST, 1999, 5 (03): : 141 - 141
  • [8] Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: Is it ecstasy or cannabis?
    Gouzoulis-Mayfrank, E
    Becker, S
    Pelz, S
    Tuchtenhagen, F
    Daumann, J
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 51 (09) : 766 - 769
  • [9] Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
    Parrott, AC
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) : 837 - 844
  • [10] Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users
    Parrott, AC
    Buchanan, T
    Scholey, AB
    Heffernan, T
    Ling, J
    Rodgers, J
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 (06) : 309 - 312
12345